For the quarter ended December 2025, Celanese (CE Quick QuoteCE - Free Report) reported revenue of $2.2 billion, down 7% over the same period last year. EPS came in at $0.67, compared to $1.45 in the year-ago quarter.

The reported revenue represents a surprise of -1.16% over the Zacks Consensus Estimate of $2.23 billion. With the consensus EPS estimate being $0.89, the EPS surprise was -24.62%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

Here is how Celanese performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Net Sales- Acetyl Chain: $940 million versus $1.01 billion estimated by three analysts on average. Compared to the year-ago quarter, this number represents a -15.3% change.
• Net Sales- Intersegment Eliminations: $-13 million versus the three-analyst average estimate of $-22.5 million. The reported number represents a year-over-year change of -38.1%.
• Net Sales- Engineered Materials: $1.28 billion compared to the $1.25 billion average estimate based on three analysts. The reported number represents a change of -0.3% year over year.

View all Key Company Metrics for Celanese here>>>

Shares of Celanese have returned +25.4% over the past month versus the Zacks S&P 500 composite's -1.4% change. The stock currently has a Zacks Rank #4 (Sell), indicating that it could underperform the broader market in the near term.